Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
- 1 June 1988
- Vol. 59 (6), 685-689
- https://doi.org/10.1136/hrt.59.6.685
Abstract
Celiprolol (400 mg) and atenolol (100 mg) were given once a day to 16 patients with stable angina pectoris in a double blind placebo controlled crossover study. Celiprolol produced less suppression of heart rate both at rest and during exercise than atenolol. Both drugs were equally effective in reducing the frequency of angina and in delaying the onset of ischaemia during exercise. Radionuclide ventriculography showed that atenolol but not celiprolol lowered cardiac output at rest and during exercise. Thus the ancillary properties of celiprolol, including partial .beta.2 agonist activity and direct vasodilating activity, have detectable effects on cardiac function that may be beneficial in patients with angina.This publication has 8 references indexed in Scilit:
- Beta-Blocking Drugs and Myocardial FunctionJournal of Cardiovascular Pharmacology, 1986
- Celiprolol in Angina PectorisJournal of Cardiovascular Pharmacology, 1986
- Celiprolol: pharmacokinetics and duration of pharmacodynamic activity.1985
- Coronary Insufficiency and β-BlockadeJournal of Cardiovascular Pharmacology, 1985
- Hemodynamic Predictors of Myocardial Oxygen Consumption During Static and Dynamic ExerciseCirculation, 1974
- Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients.1971
- Effects of Propranolol and Isosorbide Dinitrate on Exercise Performance and Adrenergic Activity in Patients with Angina PectorisCirculation, 1969
- Mode of action of nitrglycerin in angina pectoris. Correlation between haemodynamic effects during exercise and prevention of pain.Heart, 1968